MKS Instruments

MKS Instruments reported Q2 FY2026. EPS came in at $3.30 against a $2.91 consensus, beat by 13.4%. Revenue was $1.2B versus $1.2B expected, beat by 4.4%. Gross margin was 47.7%, up 650 bps from last quarter.

MKS Instruments MKS Instruments reported a strong start to the fiscal year, with both revenue and earnings per share (EPS) exceeding street estimates. The company's Q1 FY2026 results reflect a solid performance across its key markets, driven by sequential and year-over-year growth in semiconductor and electronics packaging segments.

MKS Instruments beat by only +1.1% on revenue and +0.4% on EPS, yet the print is not a simple “in line” semiconductor-cycle quarter. The market may be underpricing a barbell outcome: demand into wafer fab and advanced packaging is broad enough to support $1.04 billion Q1 revenue guidance, but the earnings power attached to that revenue is being capped by mix, seasonality, and leverage work that matters more than the headline beat.

MKS Instruments cleared the quarter on EPS and revenue, but the variant view is that the market should not pay simply for a semicap recovery multiple here: the surprise was electronics and packaging plus cash conversion, while semiconductor revenue was flat into Q4 guidance. The actionable debate is whether $147 million of free cash flow and a $100 million voluntary term-loan prepayment can keep compressing the balance-sheet discount even if gross margin stays around 46.6% to 46.7% and semi revenue sits at $415 million.

MKS Instruments beat because semiconductor and packaging demand arrived together, not because the model suddenly regained operating leverage. The variant view is that the market should underwrite the deleveraging and end-market breadth now, while refusing to capitalize a gross-margin recovery that management has not yet earned.